Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fungi Methods

ABSTRACT: Evaluation of 5 primer sets for the characterization of the gut mycobiome

PROVIDER: PRJEB29038 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2835580_1.fastq.gz	Fastqsanger.gz
	ERR2835580_2.fastq.gz	Fastqsanger.gz
	ERR2835590_1.fastq.gz	Fastqsanger.gz
	ERR2835590_2.fastq.gz	Fastqsanger.gz
	ERR2835600_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 118

Similar Datasets

Molecular methods in geomicrobiology

Project description:Evaluation of molecular techniques in characterization of deep terrestrial biosphere

| PRJEB6086 | ENA

Project description:Gut mycobiome and habitat enviromental mycobiome

| PRJNA739868 | ENA

Analysis of small ncRNAs in stool samples from ASD patients

Project description:Intestinal microorganisms impact on health maintaining gut homeostasis and shaping the host immunity, while gut dysbiosis associates with many conditions including autism, a complex neurodevelopmental disorder with multifactorial aetiology. In autism, gut dysbiosis correlates with symptom severity and is characterized by a reduced bacterial variability and a diminished beneficial commensal relationship. Microbiota can influence the expression of host microRNAs that, in turn, regulate the growth of intestinal bacteria by means of bidirectional host-gut micro-biota cross-talk. We investigated possible interactions among intestinal microbes and between them and host transcriptional modulators in autism. To this purpose, we analysed, by “omics” technologies, faecal microbiome, mycobiome and small non-coding-RNAs (particularly miRNAs and piRNAs) of children with autism and neurotypical development. Patients displayed gut dysbiosis, related to a reduction of healthy gut micro- and mycobiota, and up-regulated tran-scriptional modulators. The targets of dysregulated non-coding-RNAs are involved in intestinal permeability, inflammation and autism. Furthermore, microbial families, underrepresented in patients, participate to the production of human essential metabolites negatively influencing the health condition. Here, we propose a novel approach to analyse faeces as a whole and, for the first time, we detected miRNAs and piRNAs in faecal samples of patients with autism.

2022-03-12 | GSE198199 | GEO

Human gut

Project description:Human gut Mycobiome

| PRJNA751473 | ENA

ITS2 sequencing and targeted meta-proteomics of infant gut mycobiome reveal the functional role of Rhodotorula sp. during atopic dermatitis manifestation

Project description:Metagenomic and targeted meta-proteomics were used to investigate the mycobiome profile of the infant gut to identify proteins involved during atopic dermatitis manifestation in a Thai population-based birth cohort.

2021-09-14 | PXD027687 | JPOST Repository

human metagenome

Project description:Mycobiome characterization in Lung Cancer

| PRJNA586768 | ENA

Project description:Benchmark of 16S analysis with V12 and V34 primer sets

| PRJNA715083 | ENA

FUNGI

Project description:GUT FUNGAL METAGENOME Metagenome

| PRJNA439151 | ENA

Project description:Initial characterization of the chicken gut mycobiome and its response to BMD

| PRJNA614944 | ENA

human gut metagenome